Physician profile
Patrick Koo
NPI 1982801866
$11,232.34
in general payments reported to CMS, 2019-2025
11 companies · $3,325 in 2025
The $3,325 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $115 · 2021: $24.14 · 2022: $65.21 · 2023: $6,523 · 2024: $1,041 · 2025: $3,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,065 · Travel and Lodging: $1,201 · Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,064.96 |
| Travel and Lodging | $1,201.21 |
| Food and Beverage | $623.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,291.83 | 2023-2025 | Da Vinci Surgical System, Ion |
| Inari Medical, INC. | $150.40 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Covidien LP | $138.52 | 2019 | |
| Galvanize Therapeutics, INC | $129.98 | 2025 | Aliya System |
| Olympus America INC. | $114.58 | 2020 | |
| Inspire Medical Systems, INC. | $112.84 | 2023-2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $103.40 | 2024 | Tezspire |
| Insmed, INC. | $81.20 | 2022-2024 | Arikayce |
| Actelion Pharmaceuticals US, INC. | $67.14 | 2022-2023 | Opsumit, Uptravi |
| Vapotherm INC | $24.14 | 2021 | |
| Ethicon INC. | $18.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Koo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.